PharmaGap Inc. (GAP) Reports That GAP-107B8 Showed Strong and Consistent Anti-Cancer Activity in a Wide Range of Cancers in NCI Test
10/27/2009 1:08:01 PM
More...
|
PharmaGap Inc. (GAP) Announces Completion of Securities Lending Arrangements with Stormont
10/21/2009 2:14:09 PM
More...
|
PharmaGap Inc. (GAP) Advises That National Cancer Institute Test Results Are Completed and Expected To Be Provided To The Company Shortly
10/20/2009 2:18:14 PM
More...
|
Results from National Cancer Institute Five-Dose Study of PharmaGap Inc. (GAP) Cancer Drug Expected Late September
9/2/2009 2:58:41 PM
More...
|
PharmaGap Inc. (GAP) Advised By U.S. National Cancer Institute Of Positive Results Of Testing for the Company's Lead Cancer Drug GAP-107B8
8/13/2009 2:02:15 PM
More...
|
PharmaGap Inc. (GAP) Releases Results of Initial Testing For Novel Cancer Drug Compound at the Ottawa Hospital Research Institute
8/6/2009 11:54:43 AM
More...
|
PharmaGap Inc. (GAP) Provides Guidance on Cancer Drug Testing Timetable
7/17/2009 9:28:52 AM
More...
|
PharmaGap Inc. (GAP) Raises Additional Equity Financing
7/16/2009 12:33:51 PM
More...
|
PharmaGap Inc. (GAP) Announces Agreement for the Issuance of Shares to National Research Council of Canada
6/23/2009 1:56:07 PM
More...
|
PharmaGap Inc. (GAP) Announces Completion of $861,920 Private Placement
6/17/2009 11:32:45 AM
More...
|
|